Idiopathic thrombocytopenic purpura (itp) and Hyperhidrosis

Summary:

Hyperhidrosis is found among people with Idiopathic thrombocytopenic purpura (itp), especially for people who are female, 60+ old.

The study analyzes which people have Hyperhidrosis with Idiopathic thrombocytopenic purpura (itp). It is created by eHealthMe based on reports of 72 people who have Idiopathic thrombocytopenic purpura (itp) from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Idiopathic thrombocytopenic purpura (itp)?

Idiopathic thrombocytopenic purpura (itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting) is found to be associated with 279 drugs and 1,135 conditions by eHealthMe. Check the latest studies of Idiopathic thrombocytopenic purpura (itp).

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,553 drugs and 3,546 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.



On Jul, 12, 2026

72 people who have Idiopathic Thrombocytopenic Purpura (Itp) and Hyperhidrosis are studied.

Would you have Hyperhidrosis when you have Idiopathic thrombocytopenic purpura (itp)?

Gender of people who have Idiopathic Thrombocytopenic Purpura (Itp) and experienced Hyperhidrosis *:

  • female: 69.57 %
  • male: 30.43 %

Age of people who have Idiopathic Thrombocytopenic Purpura (Itp) and experienced Hyperhidrosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.36 %
  • 30-39: 10.71 %
  • 40-49: 19.64 %
  • 50-59: 12.5 %
  • 60+: 51.79 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 11 people, 15.28%
  2. Diabetes: 6 people, 8.33%
  3. Thrombocytopenic Purpura (a bleeding disorder in which the immune system destroys platelets): 5 people, 6.94%
  4. Chest Pain: 4 people, 5.56%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 5.56%
  6. High Blood Cholesterol: 4 people, 5.56%
  7. Mean Arterial Pressure (an average blood pressure in an individual): 3 people, 4.17%
  8. Parkinson's Disease: 3 people, 4.17%
  9. Blood Prolactin Increased: 3 people, 4.17%
  10. Platelet Count Abnormal: 3 people, 4.17%

Common drugs taken by these people *:

  1. Nplate: 13 people, 18.06%
  2. Metformin: 9 people, 12.50%
  3. Calcium: 7 people, 9.72%
  4. Novorapid: 6 people, 8.33%
  5. Rituxan: 5 people, 6.94%
  6. Insulin: 5 people, 6.94%
  7. Eliquis: 4 people, 5.56%
  8. Aldactone: 4 people, 5.56%
  9. Vitamin D3: 4 people, 5.56%
  10. Lantus: 4 people, 5.56%

Common symptoms for these people *:

  1. Thrombocytopenia (decrease of platelets in blood): 34 people, 47.22%
  2. Headache (pain in head): 33 people, 45.83%
  3. Fatigue (feeling of tiredness): 30 people, 41.67%
  4. Malaise (a feeling of general discomfort or uneasiness): 28 people, 38.89%
  5. Weakness: 25 people, 34.72%
  6. Joint Pain: 22 people, 30.56%
  7. Pain In Extremity: 21 people, 29.17%
  8. High Blood Pressure: 20 people, 27.78%
  9. Pain: 18 people, 25.00%
  10. Head Injury: 18 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hyperhidrosis:

All the conditions that are associated with Hyperhidrosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperhidrosis and Idiopathic thrombocytopenic purpura (itp), and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: